Urosepsis is sepsis that derives from a urogenital tract infection  . In 20% - 30% of sepsis patients, the infection originates from the urinary tract, and urosepsis often develops from urinary tract infections (UTIs) acquired in a community or hospital  . About 5% - 7% of severe sepsis originates from UTI  . In previous study, the following are high-risk factors for urosepsis: Old age, female gender, diabetes, immunosuppression (organ transplantation), use of chemotherapy or steroids, AIDS, chronic renal failure, anemia, diameter of stone >2.5 cm and extremely long operation time  . Urosepsis is most commonly caused by Escherichiacoli  .Two thirds of urosepsis caused Escherichia coli was extended spectrum beta-lactamase (ESBL) producers  . Although Escherichia coli induced urosepsis were predominant, little is known of the recent epidemiology of urosepsis associated Escherichia coli infection compared to others in Japan. The present study was conducted to find out the clinical characteristics of Escherichia coli isolates at tertiary care university hospital in the centre of Japan. Our result would be useful for contributing to larger more extensive surveillance study.
2. Materials and Methods
2.1. Strains and Clinical Data Collection
A total of one hundred five Escherichia coli were obtained from various clinical specimens at Nagoya City University hospital from 2008 to 2011. Nagoya City University hospital is an 808-bed tertiary care university hospital in the central region of Japan. We used medical records appended to clinical species for the analysis of clinical feature at Nagoya City University Hospital. We considered several isolates from the same region of the same patient as one isolate per one patient for the analysis in this study. All Escherichia coli isolates were identified by standard conventional biochemical methods or the VITEK2 system (bioMérieux, Durham NC, USA). Our experimental design was approved by the ethics committee at Nagoya City University.
2.2. Antimicrobial Susceptibility Analysis
Escherichia coli isolates were examined for 11 antibiotic susceptibilities as follow ABPC; ampicillin, PIPC; piperacillin, CEZ; cefazolin, CAZ; ceftazidime, CTX; cefotaxime, CFPM; cefepime, AZT; aztreonam, GM; gentamicin, MINO; minocycline, CPFX; ciprofloxacin, ST; trimethoprim-sulfamethoxazole. Minimal inhibitory concentration (MICs) were determined using broth micro dilution methodology with the VITEK2 system. Evaluation of antimicrobial resistance was based on Clinical Laboratory Standard Institute (CLSI) break point (M100-S20)  .
2.3. Statistical Analysis of the Data
We conducted the statistical analysis with the chi-squared test or Fisher’s exact test when appropriate. Differences were considered significant when p was <0.05.
One hundred five Escherichia coli were isolated in this study. Of them, fifty-three were from urosepsis, and fifty-two were from other disease.
With regard to gender, the numbers of females from urosepsis tended to be higher than those from others (Table 1).
Table 1. Clinical characteristics between urosepsis and no urosepsis Escherichia coli.
Forty-two isolates were from outpatient and sixty-three were from inpatient. The numbers of inpatients from no urosepsis were significant lower than those from urosepsis (p = 0.02) (Table 1). With respect to age, the numbers of elder patients were higher than those of others. However, there were significant differences of the patients between urosepsis and others (Table 1). Most of the Escherichia coli isolates were from the emergency room followed by urology, and general medicine. There were significant differences of the patients at urology department between urosepsis and others (p = 0.03) (Table 1).
Moreover, the results of antimicrobial resistant pattern of Escherichia coli isolates to various antibiotics tested in this study are shown in Table 2. We found the significant differences of aztreonam resistant pattern between urosepsis and others (p = 0.049).
In this study, we described the characteristics of urosepsis-associated Escherichia coli isolates from 2008 to 2011 at tertiary care university hospital in the central region of Japan.
The ratio of male to female from urosepsis is lower than that from others. Other study also showed that the difference in gender distributions was due to the fact that females were more prone to urinary infections because anatomically urethra is short.  . Our study was consistent with this hypothesis.
The ratio of outpatients to inpatients from urosepsis is higher than that from others, because there are many opportunities for collecting sampling from an outpatient.
The prevalence of urology department is higher than others, because urology is a specialist dealing with urinary tract infection.
With respect to antibiotics resistant, the prevalence of aztreonam resistant was only higher than others in our study. As we did not find any significant differences of antimicrobial resistant pattern except aztreonam between urosepsis and others, our results
Table 2. Antimicrobial resistant pattern between urosepsis and no urosepsis Escherichia coli.
suggest that we do not need to selectively use the antibiotic by diseasessuch as urosepsis. As geographical variation existed in the antibiotics resistance rates, the resistant rate of ampicillin/beta lactamase inhibitor, gentamicin and piperacillin/tazobactam + gentamicin was statistically significant in urosepsis  . In other study, resistance rates in urosepsis were higher than in other clinical diagnosis  . Our result suggested that aztreonam use might require careful administration with consideration of results of drug susceptibility.
In this study, we did not focus on postoperative status as a major consideration. In the previous study, the proportion of females (53%) was basically similar to other studies, but the proportion of postoperative patients was obviously increased  . It should be noted that, among hospital-acquired UTIs treated by urinary surgery, the mean incidence rate of urosepsis was 12%, but, in other fields, the incidence rates of severe sepsis and septic shock were 2% and 0.3%, respectively  . But our study did not show that there were significant differences of urosepsis incidence among departments of surgical system except urology. We need re-evaluate this point in further study.
Again, urosepsis is generally reported to have low mortality rates and favorable outcomes compared with sepsis induced in other organ/system or tissues. Rapid and appropriate management of sepsis, including the administration of an initially adequate intravenous antibacterial, is essential for optimal outcomes  . This should be considered by the use of suitable antibiotics in high-risk patients  .
We need enough attention to be paid to urosepsis, especially female and elder patients. Further investigation about recent urosepsis situation in Japan will be desired.
Conflict of Interest
The authors declare that they have no conflict of interests.
We thank Mr. Masashi Ishihara and Ms. Miwako Fujimura for special encouragement. This study was supported by a grant-in-aid for research from the Nagoya City University, Japan.
 Wagenlehner, F.M., Lichtenstern, C., Rolfes, C., Mayer, K., Uhle, F., Weidner, W., et al. (2013) Diagnosis and Management for Urosepsis. International Journal of Urology, 20, 963-970.
 Brun-Buisson, C. (2000) The Epidemiology of the Systemic Inflammatory Response. Intensive Care Medicine, 26, S64-S74.
 Hotchkiss, R.S. and Karl, I.E. (2003) The Pathophysiology and Treatment of Sepsis. The New England Journal of Medicine, 348, 138-150.
 Nicolle, L.E. (1997) Asymptomatic Bacteriuria in the Elderly. Infectious Disease Clinics of North America, 11, 647-662.
 DasGupta, R., Sullivan, R., French, G. and O’Brien, T. (2009) Evidence-Based Prescription of Antibiotics in Urology: A 5-Year Review of Microbiology. BJU International, 104, 760-764.
 Saravu, K., Prasad, M., Eshwara,V.K. and Mukhopadhyay. C. (2015) Clinico-Microbio-logical Profile and Outcomes of Nosocomial Sepsis in an Indian Tertiary Care Hospital—A Prospective Cohort Study. Pathogens and Global Health, 109, 228-235.
 Clinical and Laboratory Standards Institute (2014) Performance Standards for Antimicrobial Susceptibility Testing: 24st Information Supplement. Clinical and Laboratory Standards Institute M100-S24, Wayne.
 Tandogdu, Z., Bartoletti, R., Cai, T., Çek, M., Grabe, M., Kulchavenya, E., et al. (2016) Antimicrobial Resistance in Urosepsis: Outcomes from the Multinational, Multicenter Global Prevalence of Infections in Urology (GPIU) Study 2003-2013. World Journal of Urology, 34, 1193-1200.
 Qiang, X.H., Yu,T.O., Li, Y.N. and Zhou, L.X. (2016) Prognosis Risk of Urosepsis in Critical Care Medicine: A Prospective Observational Study. BioMed Research International, 2016, 9028924.
 Bjerklund, Johansen,T.E., Cek, M., Naber, K., Stratchounski, L., Svendsen, M.V., Tenke, P., PEP and PEAP Study Investigators; European Society of Infections in Urology (2007) Prevalence of Hospital-Acquired Urinary Tract Infections in Urology Departments. European Urology, 51, 1100-1111.
 Dellinger, R.P., Levy, M.M., Rhodes, A., Annane, D., Gerlach, H., Opal, S.M., et al., Surviving Sepsis Campaign Guidelines Committee Including the Pediatric Subgroup (2013) Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2012. Critical Care Medicine, 41, 580-637.